Synapsoft logo
AI Insights from Disclosures
Searching...
Dx & Vx Co., Ltd. 180400
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Dx & Vx Co., Ltd. is a biohealthcare company whose business is divided into medical diagnostics, healthcare, and new drugs. In 2022, the company acquired Korea Biopharm, a health functional food manufacturer, and in 2023 it established a subsidiary, Beijing Diaiweisi Biotechnology Co., Ltd., in China to boost exports.
Representative Director Kim Yeongjong
Founded June 16, 2001
Corporation Type KOSDAQ
Industry Classification Other scientific and technical services
Corporate number 11011-2262890
Business number 101-81-71321
Phone Number 02-890-8700
Fax Number 02-890-8702
Website www.dxvx.com
Company Address 234 Beotkkot-ro, Geumcheon-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant